BindingDB logo
myBDB logout

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28692292 73 Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers.EBI Sichuan University and Collaborative Innovation Center For Biotherapy
26762835 342 Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2).EBI Icahn School of Medicine At Mount Sinai
26275681 15 Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1.EBI University of California
21413800 56 A one-pot synthesis and biological activity of ageladine A and analogues.EBI Macquarie University
22037378 31824 Comprehensive analysis of kinase inhibitor selectivity.EBI Ambit Biosciences
19654408 2521 AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).EBI Ambit Biosciences
31859507 212 Discovery of BAY-985, a Highly Selective TBK1/IKK? Inhibitor.EBI Bayer
31693351 473 Discovery of 4EBI TBA
30384048 365 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.EBI University of Florida
31526603 379 Structure-based rational design of staurosporine-based fluorescent probe with broad-ranging kinase affinity for kinase panel application.EBI Takeda Pharmaceutical
29211480 64 Design of Small Molecule Autophagy Modulators: A Promising Druggable Strategy.EBI China Pharmaceutical University
29561612 5 Small-Molecule Activator of UNC-51-Like Kinase 1 (ULK1) That Induces Cytoprotective Autophagy for Parkinson's Disease Treatment.EBI Sichuan University
29259744 30 HTS and Structure Based Optimization of Indazole-Derived ULK1 Inhibitors.EBI The Scripps Research Institute
29509411 8 UNC-51-like Kinase 1: From an Autophagic Initiator to Multifunctional Drug Target.EBI Sichuan Universitt China Hospital